References

Ammicuci et al (2000) Antenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin. Chem. 46: 301-302

Chiu et al (2002a) Non-invasive antenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin. Chem 48:778-780

Chiu et al (2002b) Antenatal exclusion of beta thalassemia major by examination of maternal plasma. Lancet 360: 998-1000.

Farina et al (2003) Evaluation of cell-free fetal DNA as a second trimester maternal serum marker of Down syndrome pregnancy. Clin. Chem. 49: 239-242

Finning et al (2004) A Clinical Service n the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann. N.Y. Acad.Sci 1022: 119-123

González-González et al (2002) Antenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat. Diagn 22:946-948

Leung TN et al (2001) Increased maternal plasma fetal DNA concentration in women who eventually develop preeclampsia. Clin. Chem. 47: 137-139

Levine RJ et al (2004) Two stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am. J. Obstet.Gyneco. 190(3):707-13

Lo YM et al (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for non invasive antenatal diagnosis. Am. J. Hum. Genet. 62:768-755

Lo et al (1999) Rapid clearance of fetal DNA from maternal plasma. Am. J. Hum. Genet. 64: 218-224

Rijnders et al (2004) Cell-free fetal DNA is not present in plasma of non-pregnant mothers. Clin. Chem. 20:679-681

Saito e tal (2000) Antenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 365: 1170

Wataganara T, Bianchi DW (2004) Fetal Cell-free nucleic acids in the maternal circulation. Ann. N.Y. Acad. Sci. 1022:1-10